Orlistat Is a Novel Inhibitor of Fatty Acid Synthase with Antitumor Activity

Steven J. Kridel(Wake Forest University), Jeffrey W. Smith(Sanford Burnham Prebys Medical Discovery Institute)
Cancer Research
March 15, 2004
Cited by 597


Related Papers